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A wide range of vascular burden factors has been identified to impact vascular function and
structure as indicated by carotid intima–media thickness (IMT). On the basis of their impact
on IMT, vascular factors may be selected and clustered in a vascular burden index (VBI).
Since many vascular factors increase the risk of Alzheimer’s disease (AD), a multifactorial
neurodegenerative VBI may be related to early pathological processes in AD and cognitive
decline in its preclinical stages. We investigated an elderly cohort at risk for neurodegener-
ation (TREND study, n=1102) for the multifactorial influence of vascular burden factors on
IMT measured by ultrasound.To create a VBI for this cohort, vascular factors and their def-
initions (considering medical history, medication, and/or blood marker data) were selected
based on their statistical effects on IMT in multiple regressions including age and sex.The
impact of theVBI on cognitive performance was assessed using theTrail-MakingTest (TMT)
and the consortium to establish a registry for Alzheimer’s disease (CERAD) neuropsycho-
logical battery. IMT was significantly predicted by age (standardized β=0.26), sex (0.09;
males> females) and the factors included in the VBI: obesity (0.18), hypertension (0.14),
smoking (0.08), diabetes (0.07), and atherosclerosis (0.05), whereas other cardiovascular
diseases or hypercholesterolemia were not significant. Individuals with 2 or more VBI fac-
tors compared to individuals without had an odds ratio of 3.17 regarding overly increased
IMT (≥1.0 mm).The VBI showed an impact on executive control [log(TMT B−A), p=0.047]
and a trend toward decreased global cognitive function (CERAD total score, p=0.057)
independent of age, sex, and education. A VBI established on the basis of IMT may help
to identify individuals with overly increased vascular burden linked to decreased cognitive
function indicating neurodegenerative processes. The longitudinal study of this risk cohort
will reveal the value of the VBI as prodromal marker for cognitive decline and AD.
Keywords: vascular burden, carotid intima-media thickness, trail-making test, CERAD neuropsychological battery,
prodromal marker, neurodegeneration, Alzheimer’s disease,Tübinger evaluation of risk factors for early detection
of neurodegeneration (TREND) study
INTRODUCTION
The circulatory and metabolic functions of the vascular system
underlying the reliable supply of oxygen and nutrients can be com-
promised by a wide range of factors. Pathological processes as well
as lifestyle factors may affect vascular structure and function dur-
ing life span. For instance, cardiovascular diseases, atherosclerosis,
stroke, diabetes, hypertension, as well as smoking, obesity, hyper-
cholesterolemia, and lack of physical activity have been associated
with altered vascular structure (Salonen and Salonen, 1991; Fol-
som et al., 1994; Bots et al., 1997; van Popele et al., 2001; Urbina
et al., 2002; Kotsis et al., 2006; Baldassarre et al., 2010; Engelen
et al., 2012; Niu et al., 2013; van den Oord et al., 2013). Specifi-
cally, these studies showed an association of these vascular factors
with structural increases in the intima–media thickness (IMT) of
the common carotid artery (CCA). Increased IMT has been shown
to serve as an indicator of vascular age (Stein et al., 2004) and arte-
rial stiffness (van Popele et al., 2001), and to represent a strong
predictor of clinical cardiovascular events (Lorenz et al., 2007).
Clustering of multiple factors into a cumulative vascular burden
index (VBI) has been shown to predict IMT better than single
factors do (Urbina et al., 2002; Baldassarre et al., 2010; Niu et al.,
2013) suggesting a converging impact of multiple different factors
on IMT.
Other indices have been established comprising (car-
dio)vascular as well as other factors, such as age and sex, to
estimate the annual risk of stroke for patients with atrial fibrillation
(CHA2DS2-VASc score; Olesen et al., 2011) or the 10-year cardio-
vascular risk of an individual (Framingham risk score; D’Agostino
et al., 2008). While these (cardio)vascular risk indices have a
high validity and specificity for particular diseases, they may not
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indicate vascular burden as relevant for other pathologies, e.g.,
neurodegenerative disease such as Alzheimer’s disease (AD).
For the risk evaluation of AD an individual quantification of
vascular burden mediated through multiple vascular factors asso-
ciated with AD is crucial for two main reasons. (1) Chronic brain
hypoperfusion leading to cerebral hypoxia represents an impor-
tant aspect of neurodegenerative processes in AD and vascular
dementia (Breteler, 2000; Zlokovic, 2005; de la Torre, 2012b), and
often precedes the first cognitive symptoms by many years (Chao
et al., 2010; de la Torre, 2012a). (2) Many vascular factors such
as hypertension, diabetes, obesity, hypercholesterolemia, smoking,
or stroke have been shown to increase the AD risk (Breteler, 2000;
Honig et al., 2003; Kivipelto et al., 2005; Kivipelto and Solomon,
2006; Purnell et al., 2009; Cataldo et al., 2010) and the conversion
from mild cognitive impairment (MCI) to AD (Li et al., 2011).
A VBI may therefore be of particular importance for longitudinal
studies, where vascular burden may predict AD or help to detect
its early preclinical stages.
Decreased cognitive function as assessed using well-established
neuropsychological tests is characteristic for MCI and AD and key
to their diagnosis (Hort et al., 2010). Neurodegenerative processes
as well as cognitive decline precede the clinical diagnosis of MCI
and AD (Smith et al., 2012; Langbaum et al., 2013; Moghekar
et al., 2013; Lim et al., 2014). Given the important role of vascular
burden factors in the etiology of AD, the impact of a VBI on cog-
nitive function in non-demented elderly individuals may validate
its relevance for the early detection of MCI and AD.
In the present study, we used vascular risk factors of AD show-
ing an impact on IMT to establish a VBI in a large cohort of
non-demented, elderly individuals [Tübinger evaluation of risk
factors for early detection of neurodegeneration (TREND) study,
n= 1102, 51–84 years, (Hobert et al., 2011; Berg, 2012; Maet-
zler et al., 2012; Heinzel et al., 2013; Gaenslen et al., 2014)].
We hypothesized that this multifactorial VBI may contribute to
neurodegenerative aging processes. To validate this link, we inves-
tigated this cohort at risk for neurodegeneration for the impact of
the VBI on cognitive performance in neuropsychological tests.
MATERIALS AND METHODS
PARTICIPANTS
All individuals included in the present analyses (n= 1102; 528
female, 574 male) participated in the first follow up of the TREND
study (March 2011 to April 2012), which represents the baseline
assessment with regard to the IMT ultrasound measurements. The
prospective and longitudinal TREND study aims to identify risk
markers for the prediction of AD and Parkinson’s disease (PD),
respectively, in non-demented elderly individuals who are inves-
tigated every 2 years. Participants were partly selected due to the
presence of prodromal risk markers of AD and PD, respectively,
including REM-sleep disorder, hyposmia, and/or depression. For a
detailed outline of the TREND study, further inclusion and exclu-
sion criteria and TREND baseline assessments, see Berg (2012).
The study was approved by the ethical committee of the Med-
ical Faculty of the University of Tübingen (Nr. 90/2009BO2). All
procedures were in accordance with the Declaration of Helsinki
in its latest version, and all participants gave written informed
consent.
VASCULAR BURDEN INDEX
In order to establish a VBI for the TREND cohort, we first inves-
tigated AD-associated vascular risk factors with different possible
definitions (see below) for their effect size regarding IMT predic-
tion. We then selected single factors and definitions yielding the
best prediction of IMT (independent of age and sex) in multi-
ple regression analyses (see Statistics). The cumulative number of
these selected factors/definitions was used as VBI.
VASCULAR BURDEN FACTORS
Vascular risk factors, diseases and medication data of the TREND
study were assessed with questionnaires and personal medical his-
tory interviews. The following factor definitions were included in
the analyses (see also Table 1).
Diabetes
Life-time diagnosis of diabetes (factor label: medical history),
additional intake of antidiabetic medication (medical history
or medication), and glycated hemoglobin (HbA1c) levels of
HbA1c≥ 6.5% (Kilpatrick et al., 2009) (medical history or med-
ication or HbA1c) were considered as factors definitions.
Hypertension
Life-time diagnosis of hypertension (medical history), intake of
anti-hypertensive medication alone (medication), diagnosis and
medication intake (medical history and medication), and diag-
nosis and non-diagnosis with medication intake (medical his-
tory or normal with medication) alternatively defined the factor
hypertension.
Hypercholesterolemia
Positive medical history and/or intake of lipid-lowering medica-
tion were considered for factor definitions.
Cardiovascular disease/cardiac conditions
Life-time diagnosis of atherosclerosis, atrial fibrillation, cardiac
arrhythmia, myocardial infarction, congestive heart failure, and
coronary heart disease, were each independent factor definitions.
Obesity
A body mass index (BMI; mass [kg]/(height [m])2) above 30
(obese class I) and BMI >35 (obese class II) was considered. BMI
data of 10 participants were missing.
Smoking
Personal history of smoking behavior was indicated by“pack years”
quantifying the packs (of 20 cigarettes) smoked per day multiplied
by years as a smoker. Due to lack of consensus, we arbitrarily set the
factor threshold to 5, 10, 15, and 20 pack years as factor definitions.
For 40 former smokers, pack years data were not available.
Due to lack of vascular factor data the VBI could not be
calculated for a total of 50 individuals.
ULTRASONOGRAPHY
We performed ultrasonographic measurements of the right CCA
using an ACUSON Antares™ ultrasound system (Siemens, Erlan-
gen, Germany) and a 5–10 MHz linear array transducer (VF10-5,
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Table 1 | Multiple regression analyses of intima-media thickness (IMT) and single putative vascular burden factors.
Vascular factor Alternative factor definitions Definition-dependent
subgroup size
(indicated/total)
Predictor statistics Full regression
model
β B SE(B) t -Value p-Value R2 F -value
Diabetes Medical history 83/1102 0.067 0.039 0.017 2.30 0.021 0.088 35.30
Medical history or medication 86/1102 0.065 0.038 0.017 2.25 0.025 0.088 35.22
Medical history or medication or
HbA1ca
102/1102 0.074 0.040 0.016 2.56 0.011 0.089 35.75
Hypertension Medical historya 454/1102 0.138 0.043 0.009 4.73 <0.001 0.102 41.52
Medication 463/1102 0.102 0.032 0.009 3.44 0.001 0.093 37.67
Medical history and medication 408/1102 0.126 0.040 0.009 4.28 <0.001 0.099 40.05
Medical history or normal with
medication
593/1102 0.115 0.036 0.009 3.93 <0.001 0.096 39.00
Hypercholesterolemia Medical history 460/1102 0.028 0.009 0.009 0.96 0.337 0.084 33.71
Medication 201/1102 0.013 0.005 0.012 0.46 0.647 0.084 33.45
Medical history and medication 156/1102 0.017 0.008 0.013 0.59 0.556 0.084 33.50
Medical history or normal with
medication
505/1102 0.026 0.008 0.009 0.89 0.371 0.084 33.67
Cardiovascular
disease/cardiac
conditions
Atherosclerosisa 57/1102 0.051 0.036 0.020 1.75 0.080 0.086 34.49
Atrial fibrillation 44/1102 −0.027" −0.022" 0.023 −0.93" 0.353 0.084 33.69
Cardiac arrhythmia 121/1102 −0.012" −0.006" 0.014 −0.41" 0.682 0.084 33.44
Myocardial infarction 34/1102 −0.033" −0.030" 0.026 −1.14 0.255 0.085 33.85
Congestive heart failure 35/1102 −0.001" −0.001" 0.026 −0.003" 0.973 0.084 33.38
Coronary heart disease 48/1102 0.003 0.003 0.022 0.12 0.906 0.084 33.38
Obesity BMI >30a 156/1092 0.176 0.078 0.013 6.15 <0.001 0.116 47.47
BMI >35 32/1092 0.104 0.096 0.027 3.59 <0.001 0.097 39.09
Smoking Pack years >5 282/1062 0.034 0.012 0.011 1.13 0.259 0.084 32.15
Pack years >10 228/1062 0.070 0.027 0.011 2.37 0.018 0.087 33.72
Pack years >15a 156/1062 0.076 0.034 0.013 2.57 0.010 0.088 34.09
Pack years >20 115/1062 0.072 0.037 0.015 2.44 0.088 0.088 33.86
aIndicates the factor definition with the largest β-value and thus selected VBI factor; β indicates the standardized regression coefficient of the predictor in the multiple
regression model; B indicates the non-standardized β; and SE(B) its standard error.
Siemens, Erlangen, Germany). Participants were examined in a
supine position. The CCA was differentiated from the internal
jugular vein in a transverse plane and then displayed in a longitu-
dinal scan while the course of the CCA was followed to the carotid
bulb. The IMT of the CCA was defined as the distance between the
echogenic intima-line and the echogenic media–adventitia border
at the far-wall of the CCA (Touboul et al., 2012). IMT was mea-
sured 1 cm proximal to the carotid bulb in a segment free of plaque
using a fourfold magnification of the ultrasound image (Engelen
et al., 2012). After visual inspection image quality at the site of
measurement was verified by an experienced sonographer.
COGNITIVE TESTING
Participants performed established and standardized cognitive
tests including the Trail-Making Test (TMT; Corrigan and
Hinkeldey, 1987; Bowie and Harvey, 2006; Sanchez-Cubillo et al.,
2009) and the consortium to establish a registry for Alzheimer’s
disease (CERAD) neuropsychological battery (Morris et al., 1989).
The administered TMT is a paper-and-pencil task and consists
of two parts: for the TMT Part A participants connect randomly
distributed numbers (1–25) in ascending numerical order. For the
TMT Part B participants connect randomly distributed numbers
(from 1 to 13) and letters (from A to L) in alternating numeric
and alphabetical order (1–A–2–B–3–C– . . . –13–L). In case of
errors, immediate feedback is provided by the examiner, so that
the participant completes the task without errors (at the expense
of additional time) (Bowie and Harvey, 2006). TMT performance
was indicated by the time [s] for completing TMT Part B minus
the time needed for TMT Part A. The difference TMT B−A rep-
resents an effective performance measure of cognitive control and
executive functioning, where potential bias due to differences in
upper extremity motor speed, simple sequencing, visual scan-
ning, and psychomotor functioning are minimized (Corrigan and
Hinkeldey, 1987; Sanchez-Cubillo et al., 2009).
The CERAD is composed of five subtests including ani-
mal naming, modified Boston Naming Test, Mini-Mental State
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Examination (MMSE), constructional praxis, and word list mem-
ory, which have been shown to represent valid and reliable
measures of cognitive performance in the elderly and in AD
patients (Welsh-Bohmer and Mohs, 1997). The total score of
the CERAD battery has been shown to provide an effective
global measure of cognitive functioning for the English as well
as for the German version of the CERAD used in the present
study (Chandler et al., 2005; Ehrensperger et al., 2010). The
total score ranges between 0 and 100 and comprises the raw
scores of the CERAD animal naming (verbal fluency; maxi-
mum of 24 points), modified Boston Naming Test (15 points),
word list learning (30 points), constructional praxis (11 points),
word list recall (10 points), and word list recognition discrim-
inability (10 points) (Chandler et al., 2005; Ehrensperger et al.,
2010).
STATISTICS
First, we aimed to identify vascular burden factors (with the defin-
ition yielding the largest effect size), which predict IMT indepen-
dent of age and sex. Therefore, we calculated multiple regressions
(inclusion algorithm) with IMT as criterion variable, and age, sex
(dummy variable: female= 0, male= 1), and the vascular burden
factor of interest as predictors. Vascular burden factors showing
a statistical trend (p< 0.1) of prediction of increased IMT were
included in the VBI. For these factors the definition/threshold of
the highest effect size as measured by the standardized β coefficient
of the predictor was chosen.
Second, we investigated the association of the VBI with (patho-
logical) IMT extremes. Current guidelines suggest an IMT of
0.9 mm as a conservative estimate of common carotid IMT abnor-
malities (Mancia et al., 2007). Therefore, we calculated the odds
ratio (OR) and the 95% confidence interval (CI) comparing indi-
viduals without vascular burden factors with individuals possess-
ing 1 or 2+ factors, respectively, and their frequency of falling into
the 75% (IMT <0.9 mm) and 90% percentile (IMT <1.0 mm) of
the IMT distribution of the sample.
Third, we analyzed the impact of the VBI on cognitive per-
formance. Univariate analyses of covariance using the TMT
(log10[TMT B−A]; logarithmized due to non-normality) or
the CERAD total score as dependent variables, the VBI (0,
1, 2+ vascular burden factors) as between-subject factor, and
age, sex, and education as covariates were performed. Educa-
tion level was coded according to the International Standard
Classification of Education (ISCED-97) of the UNESCO (http:
//www.unesco.org/) as low (level 1–2; primary education and
secondary education first stage), medium (3–4; secondary and
post-secondary, non-tertiary education), and high (5–6; tertiary
education).
Post hoc t -tests were performed and the significance threshold
was set to α<5%, and to α<10% for statistical trends for all tests.
RESULTS
SAMPLE CHARACTERISTICS
The mean age (±SD) of the cohort was 65.1± 6.8 years
(range: 50.8–83.7 years). Compared to males (66.0± 6.7; 51.6–
82.2), females (64.4± 6.8; range: 50.8–83.7) were younger
(t 1100=−4.09, p< 0.001). Males had higher education levels
(low: 0.9%, medium: 49.5%, and high: 49.5%) than females
(11.2%, 61.4%, and 27.5%; χ2= 91.55, p< 0.001).
INTIMA–MEDIA THICKNESS
The IMT had a mean value of 0.76± 0.16 mm. Females had lower
IMT values than males (0.74± 0.15 mm versus 0.77± 0.16 mm,
t 1100=−4.00, p< 0.001).
EFFECTS OF SINGLE VASCULAR FACTORS ON IMT
The prevalence of the vascular burden factors is given in Table 1.
IMT was significantly predicted by age (mean β-value (±SD) of
the 23 multiple regressions: 0.262± 0.011,p< 0.001) as well as sex
(0.087± 0.006, p< 0.05).
Independent of these age and sex effects several vascular bur-
den factors significantly predicted IMT. Obesity (BMI >30) was
the strongest IMT predictor (β= 0.176), followed by hypertension
(medical history;β= 0.138), smoking (pack years>15;β= 0.076),
and diabetes (medical history/medication+HbA1c; β= 0.074),
while atherosclerosis showed a statistical trend of IMT predic-
tion (β= 0.051, p= 0.080). These vascular burden factors were
therefore selected to be included in the VBI. The full regression
models [including the predictors age, sex, and single (significant)
vascular burden factors] explained between 8.6 and 11.6% of the
IMT variance.
No significant IMT prediction was found for other cardio-
vascular diseases/conditions (p> 0.3) or hypercholesterolemia
(p> 0.3) in regression models including age and sex as
predictors.
VASCULAR BURDEN INDEX IN ASSOCIATION WITH IMT
The number of selected vascular burden factors (VBI) showed an
effect size of β= 0.203 with regard to IMT prediction independent
of age and sex. The full model (age, sex, VBI) explained 12.4% of
IMT variance. For the VBI groups (0, 1, 2+ vascular burden fac-
tors), the mean IMT values corrected for age and sex are shown
in Figure 1. The VBI was correlated with age (Spearman ρ= 0.11,
p< 0.001), but did not differ between males and females (logistic
regression including age; p= 0.53).
After selection of the single vascular burden factors on the basis
of their effects on IMT the impact of the cumulative number of
these factors (VBI) on pathological IMT values was investigated.
FIGURE 1 | Mean IMT (with standard error of the mean; SEM)
corrected for age, sex, and education of the VBI groups.
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The VBI was significantly related to the frequency of individuals
being in the upper 25% (≥ 0.9 mm; χ2= 35.77, p< 0.001) or the
upper 10% (≥ 1.0 mm;χ2= 27.62, p< 0.001) of the IMT distrib-
ution. Individuals with one compared with those without vascular
burden factors had an OR of 1.68 (95% CI: 1.21–2.33) of being
in the upper 25% of the IMT distribution. However, for individu-
als with two or more compared to those without vascular burden
factors an increased OR for the upper 25% of 2.97 (95% CI: 2.06–
4.28), and 3.17 (95% CI: 1.95–5.16) for the upper 10% of the IMT
distribution was observed.
VASCULAR BURDEN INDEX IN ASSOCIATION WITH COGNITIVE
PERFORMANCE
The VBI significantly impacted cognitive control and execu-
tive function as indicated by TMT performance (F2, 1033= 3.08,
p= 0.047). Post hoc tests showed that individuals with two or
more vascular burden factors showed lower TMT performance
(i.e., longer time for TMT B−A) compared to individuals with-
out these factors (p= 0.015). Compared to those individuals
with one vascular burden factor this performance difference
showed a statistical trend (p= 0.051). Mean values of TMT per-
formance corrected for age, sex, and education are shown in
Figure 2A.
Global cognitive functioning as indicated by the CERAD
total score showed a statistical trend of an impact of the VBI
(F2, 1043= 2.88, p= 0.057). Individuals with two or more vas-
cular burden factors showed decreased global cognitive perfor-
mance compared to individuals without (p= 0.030), or with
one vascular burden factor (p= 0.028). CERAD total score
mean values corrected for age, sex, and education are shown in
Figure 2B.
Unlike the VBI, the presence of IMT pathology (i.e., IMT≥0.9
and IMT≥1.0, respectively) showed no significant impact on cog-
nitive performance measures (p> 0.10) independent of age, sex,
and education.
DISCUSSION
In the present study, a VBI based on vascular risk factors previ-
ously associated with AD was established for a large cohort of
1102 elderly individuals at risk for neurodegenerative diseases
(TREND study). Based on the impact of single (cardio)vascular
risk factors on IMT vascular burden factors were selected to be
included in a cumulative VBI. Moreover, the relevance of this VBI
for IMT extremes as well as for cognition in the TREND cohort
was investigated.
SINGLE VASCULAR BURDEN FACTORS
The cumulative VBI established in this study comprises the fac-
tors obesity (standardized β= 0.176), hypertension (β= 0.138),
diabetes (β= 0.074), smoking (β= 0.076), and atherosclerosis
(β= 0.051), which predicted IMT independent of age (β= 0.262)
and sex (β= 0.087). However, effect sizes were small and together
with age and sex the single factors only explained between 8.6 and
11.6% of the IMT variance.
Previous studies investigating individuals in a similar age range
have consistently reported an impact of these single vascular fac-
tors on IMT. For age comparable effect sizes have been shown
FIGURE 2 | (A) Mean TMT performance (with SEM) corrected for age, sex,
and education of the VBI groups, and (B) mean CERAD total scores (with
SEM) corrected for age, sex, and education of the VBI groups.
(β= 0.276) (Rundek et al., 2013). Also, males have been shown to
have slightly higher IMT values than females (β= 0.150) (Rundek
et al., 2013).
For the BMI, a similar effect size of IMT prediction (β~ 0.1)
has been reported for elderly adults (Engelen et al., 2012). An IMT
difference of about 0.1 mm between adult normal-weighted and
obese individuals has been previously reported (Kotsis et al., 2006),
which corresponds to the effects of class I obesity (BMI >30) in
the present sample.
The small effect size of life-time diagnosis of hypertension
in the present sample is comparable to the previously reported
small effect size of IMT prediction by systolic blood pressure
(β~ 0.1) (Engelen et al., 2012), or IMT differences between elderly
normotensive and hypertensive individuals (Bots et al., 1993).
For diabetes predicting increased IMT similar effect sizes in
elderly individuals with cardiovascular diseases (β~ 0.10) and a
slightly higher effect size (β~ 0.19) in a healthy elderly population
has been reported (Engelen et al., 2012).
Smoking as defined by more than 15 pack years showed a
slightly smaller effect size as previously reported for pack years
smoking (β= 0.125) (Salonen and Salonen, 1991). However,
for current smoking effect sizes were shown to differ between
healthy, elderly individuals and sexes (men: β= 0.25, women:
β= 0.11) and elderly individuals with cardiovascular diseases
(men: β= 0.10, women: β=−0.10) (Engelen et al., 2012). Thus,
the impact of the factor smoking on IMT might be complex and
sex-dependent.
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Contrary to numerous previous studies associating atheroscle-
rosis with increased IMT (Bots et al., 1996, 1997; van Popele et al.,
2001), we only found a small effect of the factor atherosclerosis
(β= 0.051) on IMT. However, effect sizes of reported life-time
atherosclerosis (n= 57) may be small as effects on IMT prediction
were calculated to be independent of age and sex.
Other cardiovascular diseases and conditions were no signifi-
cant IMT predictors in the present study, which is in contrast to
several previous findings showing increased IMT for e.g., myocar-
dial infarction, congestive heart failure, coronary heart disease
(Bots et al., 1997; Den Ruijter et al., 2012; van den Oord et al.,
2013). The missing IMT effects in the present study might be
due to the younger age and rather small number of individu-
als with these cardiovascular pathologies, and age and sex being
confounding factors in multiple regression analyses.
Life-time diagnosis of hypercholesterolemia was no significant
IMT predictor independent of age and sex in the present study.
Recently, very small effects (β< 0.05) of IMT prediction have been
reported for the Total-to-HDL cholesterol ratio in elderly individ-
uals (Engelen et al., 2012). Also, life-time hypercholesterolemia
effects on IMT might have been ameliorated due to lipid-lowering
treatment or nutritional changes in the past.
VASCULAR BURDEN INDEX
The number of vascular burden factors (VBI) together with age
and sex explained 12.4% of the IMT variance. This percentage
corresponds to previous large studies in elderly individuals, which
showed 11% (Rundek et al., 2013), 17% (O’Leary et al., 1996), or
27% (Baldassarre et al., 2010) of IMT variance to be explained by
age, sex, and vascular burden factors (e.g., blood pressure, pack
years or current smoking, serum cholesterol or glucose levels, and
others) and factors, such as education or geographical data. How-
ever, composition of these factors included in these studies did
widely differ, and in the study by Baldassarre et al. (2010) the
IMT predictor with the largest effect size was geographical lati-
tude within Europe (partial r = 0.078), which partly explains the
large percentage (27%) of explained IMT variance.
Thus, variance of IMT as a continuous variable including
non-pathological IMT values (<0.9 mm) and (heritable) natural
differences between individuals might only be modestly explained
by vascular burden factors. This might also underlie the mod-
estly increased IMT prediction comparing the VBI (12.4%) and
the single vascular factor of largest effect size (obesity: 11.6%).
However, the impact of vascular burden factors might be better
observed for pathological IMT extremes. Here, we found a pro-
nounced impact of the number of vascular burden factors with
respect to the extreme subgroups. For instance, individuals with
two or more compared to those without vascular burden factors
showed an increased OR of 2.97 for IMT ≥0.9 mm, and an OR of
3.17 for IMT ≥1.0 mm. These findings suggest that within nor-
mal, non-pathological IMT ranges (i.e., IMT <0.9 mm) natural
and largely age- and sex-dependent interindividual IMT variabil-
ity might prevail, whereas the impact of the VBI is best observed
in subgroups of increased IMT.
The VBI was established for the TREND cohort to investigate
its predictive value for MCI and AD in future longitudinal inves-
tigations of the TREND study. Importantly, in elderly individuals,
in whom cerebral perfusion is already diminished due to aging a
high vascular load, e.g., mediated by two, three, or more vascular
burden factors, might causally underlie chronic brain hypoperfu-
sion, hypoxia, and a neuronal energy crisis critical with respect
to cellular functioning and may, hence, foster neurodegeneration
increasing the risk of AD (Li et al., 2011; de la Torre, 2012a).
Because chronic brain hypoperfusion often precedes MCI and AD
by many years, the present study identified individuals hypothe-
sized to show cognitive decline in the future due to vascular burden
factors. A recent study even showed a high association of increased
pulse wave velocity with beta-amyloid burden in elderlies (Hughes
et al., 2013) suggesting an important link between vascular and
beta-amyloid mediated pathological processes relevant to AD.
VASCULAR BURDEN INDEX AND COGNITION
The present study showed an impact of the VBI on cognition.
Individuals with two or more vascular burden factors exhibited
poorer executive function/cognitive control in the TMT and lower
global cognitive function in the CERAD neuropsychological bat-
tery compared to individuals without these factors, which was
independent of age, sex, and education. This finding indicates that
the VBI is indeed associated with cognitive performance in this
study cohort. As associations between cognitive performance and
IMT were not significant in the present study, the VBI may repre-
sent a more reliable and holistic indicator of vascular impact on
cognition, compared to (pathological) IMT alone.
Importantly, the VBI comprises vascular factors which have
previously been associated with AD. Also, by considering objec-
tive and quantitative IMT measurements for the selection of these
factors and factor definitions, the validity of the VBI indicating
vascular burden as relevant for AD in individuals of the TREND
cohort might be increased. Thus, the VBI may hold important pre-
dictive value for cognitive decline and the development of MCI and
AD, which will be further investigated in the longitudinal TREND
study.
LIMITATIONS
Several limitations have to be considered for the present study:
(1) by selecting vascular factors for the VBI based on IMT some
putative factors/definitions were not included in the VBI. This
procedure may increase sensitivity of the VBI as selected factors
actually predict increased IMT in the TREND cohort but may
also reduce its specificity by excluding factors (e.g., cardiovascular
pathologies, hypercholesterolemia). (2) We only used question-
naires and personal medical history interviews for the assessment
of vascular risk factors, diseases, and medication data. However,
it was emphasized that all indications, diagnoses, and medica-
tions must have been confirmed by a medical doctor. Moreover,
experimental blood pressure measurements were not included in
the establishment of the VBI and the identification of individuals
with increased vascular burden. Reliable (multiple) measurements
of blood pressure or other experimental vascular and laboratory
measures should be investigated in future studies for their poten-
tial to further validate or refine vascular burden estimates, such
as the VBI. (3) While total or HDL cholesterol, or fasting glu-
cose levels or other blood-derived quantitative measures were not
assessed due to assessments at different day times, we aimed to
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complement the data by also considering current medication and,
for diabetes,blood HbA1c concentrations. (4) We only assessed one
frequently investigated segment of the IMT of the right CCA as a
reference measure of vascular burden, as the design of the TREND
study favors easy to apply and quick to perform techniques, which
may well be used in other large studies or populations screen-
ings. However, other indicators including internal carotid artery
measures (Mackinnon et al., 2004), regional plaques (Zureik et al.,
2002), and arterial stiffness (van Popele et al., 2001; Hughes et al.,
2013) were not investigated, but might also be important for the
relationship between vascular burden factors and vascular func-
tionality. (5) Interactions between vascular burden factors were
not in the scope of the present study. However, their interac-
tions have been shown to only modestly improve explained IMT
variance (Niu et al., 2013). (6) The present results might not be
fully generalizable, as TREND study participants had above aver-
age education levels (39% academics) and were partly selectively
included due to the presence of prodromal markers for neurode-
generation (REM-sleep disorder, hyposmia, and/or depression)
(Berg, 2012).
CONCLUSION
Vascular function and structure as well as the risk of AD have been
shown to be influenced by a multitude of vascular factors. Based
on their impact on carotid IMT vascular factors associated with
AD can be selected to establish a neurodegenerative cumulative
VBI. The relevance of this VBI for cognition was validated by its
impact on cognitive performance in healthy, non-demented indi-
viduals at risk for neurodegeneration. The VBI may represent an
important predictor of AD and its prodromal stages, which will be
further investigated in the longitudinal TREND study.
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